BioAge Labs (BIOA) Income Statement: Revenue & Earnings

BioAge Labs Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

BioAge Labs, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00
Operating Expenses
Research & Development	59.04	33.89	30.52
Selling, General & Administrative	19.16	14.51	9.45
Operating Expenses	78.19	48.40	39.97
Operating Income	-78.19	-48.40	-39.97
Other Income/Expense
Interest Income	9.63	2.43	0.47
Interest Expense	2.37	7.79	-0.24
Other Income/Expense	7.09	-10.09	0.02
Income
Income Before Tax	-71.11	-63.85	-39.72
Income Tax Expense	0.00	0.00	0.00
Net Income	-71.11	-63.85	-39.72
Net Income - Continuous Operations	-71.11	-63.85	-39.72
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-68.58	-55.90	-39.84
EBIT	-71.15	-56.06	-39.97
Depreciation & Amortization	0.17	0.16	0.13
Earnings Per Share
Basic EPS	-7.00	-3.00	-24.00
Diluted EPS	-7.00	-3.00	-24.00
Basic Shares Outstanding	10.73	20.12	1.67
Diluted Shares Outstanding	10.73	20.12	1.67